0001752724-23-261577.txt : 20231121 0001752724-23-261577.hdr.sgml : 20231121 20231121155042 ACCESSION NUMBER: 0001752724-23-261577 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231121 DATE AS OF CHANGE: 20231121 PERIOD START: 20231231 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TEMPLETON DRAGON FUND INC CENTRAL INDEX KEY: 0000919893 IRS NUMBER: 650473580 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-08394 FILM NUMBER: 231427814 BUSINESS ADDRESS: STREET 1: 300 S.E. 2ND STREET CITY: FORT LAUDERDALE STATE: FL ZIP: 33301-1923 BUSINESS PHONE: 9545277500 MAIL ADDRESS: STREET 1: 300 S.E. 2ND STREET CITY: FORT LAUDERDALE STATE: FL ZIP: 33301-1923 NPORT-P 1 primary_doc.xml NPORT-P false 0000919893 XXXXXXXX Templeton Dragon Fund, Inc. 811-08394 0000919893 549300L5KGV2K28LYW59 300 S.E. 2nd Street Fort Lauderdale 33301-1923 954-527-7500 Templeton Dragon Fund, Inc. 549300L5KGV2K28LYW59 2023-12-31 2023-09-30 N 345481372.40 2323251.08 343158121.32 0.00000000 161650705.12000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 6281138.20000000 UST Postal Savings Bank of China Co. Ltd. 300300C1040311005298 Postal Savings Bank of China Co. Ltd., Class H N/A 11001649.00000000 NS 5540029.50000000 1.614424708554 Long EC CORP CN N 2 N N N China Resources Beer Holdings Co. Ltd. 254900OH02Y7OS7RNG48 China Resources Beer Holdings Co. Ltd. N/A 738706.00000000 NS 4035265.71000000 1.175920212664 Long EC CORP HK N 2 N N N Hundsun Technologies, Inc. 3003003LS77D1DRDDE25 Hundsun Technologies, Inc., Class A N/A 976621.00000000 NS 4362881.92000000 1.271391131067 Long EC CORP CN N 2 N N N Weichai Power Co. Ltd. 529900OKTPKBG85F9502 Weichai Power Co. Ltd., Class H N/A 2826261.00000000 NS 3830854.02000000 1.116352428222 Long EC CORP CN N 2 N N N Alibaba Group Holding Ltd. 5493001NTNQJDH60PM02 Alibaba Group Holding Ltd. N/A 2113738.00000000 NS 22918273.12000000 6.678633462568 Long EC CORP KY N 2 N N N Meituan 21380033K525E5JLIA77 Meituan Dianping, Class B N/A 759943.00000000 NS 11001431.58000000 3.205936533770 Long EC CORP KY N 2 N N N Mobvista, Inc. 655600AW50D7VN363G24 Mobvista, Inc. N/A 3098200.00000000 NS 1246290.88000000 0.363182685348 Long EC CORP KY N 1 N N N JD.com, Inc. 549300HVTWB0GJZ16V92 JD.com, Inc., Class A N/A 452312.00000000 NS 6580822.43000000 1.917723061510 Long EC CORP KY N 2 N N N China Resources Land Ltd. 5299001HL0TU7X15HK51 China Resources Land Ltd. N/A 1111375.00000000 NS 4413565.65000000 1.286160919934 Long EC CORP KY N 2 N N N Baidu, Inc. 254900AL64IANZYI1E02 Baidu, Inc., Class A N/A 559500.00000000 NS 9417061.35000000 2.744233857492 Long EC CORP KY N 2 N N N WuXi AppTec Co. Ltd. 254900OEPQLZSPLN9175 WuXi AppTec Co. Ltd., Class H N/A 274008.00000000 NS 3267685.34000000 0.952238964192 Long EC CORP CN N 2 N N Baidu, Inc. 254900AL64IANZYI1E02 Baidu, Inc. 056752108 30181.00000000 NS USD 4054817.35000000 1.181617772705 Long EC CORP KY N 1 N N N China Merchants Bank Co. Ltd. 549300MKO5B60FFIHF58 China Merchants Bank Co. Ltd., Class A N/A 1163800.00000000 NS 5296006.25000000 1.543313685722 Long EC CORP CN N 2 N N N China Merchants Bank Co. Ltd. 549300MKO5B60FFIHF58 China Merchants Bank Co. Ltd., Class H N/A 1604448.00000000 NS 6661248.84000000 1.941160190053 Long EC CORP CN N 2 N N N Kangmei Pharmaceutical Co. Ltd. 3003006FRNBUUTVKBB50 Kangmei Pharmaceutical Co. Ltd. N/A 673786.03000000 NS 114540.76000000 0.033378420291 Long EC CORP CN Y 3 N N N Jiangsu Hengrui Pharmaceuticals Co. Ltd. N/A Jiangsu Hengrui Pharmaceuticals Co. Ltd., Class A N/A 1445227.00000000 NS 8938035.48000000 2.604640521290 Long EC CORP CN N 2 N N N Hongfa Technology Co. Ltd. N/A Hongfa Technology Co. Ltd., Class A N/A 1535209.00000000 NS 7077655.23000000 2.062505530329 Long EC CORP CN N 2 N N N Inner Mongolia Yili Industrial Group Co. Ltd. 3003002Q2A863JPQFH06 Inner Mongolia Yili Industrial Group Co. Ltd., Class A N/A 1446200.00000000 NS 5277485.06000000 1.537916409991 Long EC CORP CN N 2 N N N Wuxi Biologics Cayman, Inc. 5493001TD2TH6VDTJU11 Wuxi Biologics Cayman, Inc. N/A 1195850.00000000 NS 6950332.34000000 2.025402258662 Long EC CORP KY N 2 N N N Tencent Holdings Ltd. 254900N4SLUMW4XUYY11 Tencent Holdings Ltd. N/A 828026.00000000 NS 32098590.88000000 9.353877669142 Long EC CORP KY N 2 N N N Yum China Holdings, Inc. 529900DO9BYZ7VA3K502 Yum China Holdings, Inc. 98850P109 117578.00000000 NS USD 6551446.16000000 1.909162497684 Long EC CORP US N 1 N N N Focus Media Information Technology Co. Ltd. 300300V7WGZW0LZKTD06 Focus Media Information Technology Co. Ltd., Class A N/A 13519216.00000000 NS 13264971.84000000 3.865556726145 Long EC CORP CN N 2 N N N NetEase, Inc. 5299004AF4DSJDB0PA32 NetEase, Inc. N/A 582379.00000000 NS 11677800.70000000 3.403037834302 Long EC CORP KY N 2 N N N Hong Kong Exchanges & Clearing Ltd. 213800YTVSXYQN17BW16 Hong Kong Exchanges & Clearing Ltd. N/A 90257.00000000 NS 3349794.34000000 0.976166417718 Long EC CORP HK N 2 N N N Shenzhen Mindray Bio-Medical Electronics Co. Ltd. N/A Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Class A N/A 181501.00000000 NS 6746598.01000000 1.966031864275 Long EC CORP CN N 2 N N N Guangzhou Tinci Materials Technology Co. Ltd. 836800Y28XV3QK34CB65 Guangzhou Tinci Materials Technology Co. Ltd., Class A N/A 1123280.00000000 NS 4170669.43000000 1.215378325874 Long EC CORP CN N 2 N N N Ping An Insurance Group Co. of China Ltd. 529900M9MC28JLN35U89 Ping An Insurance Group Co. of China Ltd., Class H N/A 1987427.00000000 NS 11272344.58000000 3.284883521520 Long EC CORP CN N 2 N N N BYD Co. Ltd. 5299005557VL7ULJ7A69 BYD Co. Ltd., Class A N/A 86000.00000000 NS 2813378.50000000 0.819849021546 Long EC CORP CN N 2 N N N ANTA Sports Products Ltd. 529900291XG0CTK4LF95 ANTA Sports Products Ltd. N/A 1110075.00000000 NS 12421406.99000000 3.619732775730 Long EC CORP KY N 2 N N N Haier Smart Home Co. Ltd. 3003002BYTNGNJTWSH07 Haier Smart Home Co. Ltd., Class A N/A 1278400.00000000 NS 4156600.43000000 1.211278466617 Long EC CORP CN N 2 N N N Kweichow Moutai Co. Ltd. N/A Kweichow Moutai Co. Ltd., Class A N/A 65445.00000000 NS 16236852.27000000 4.731594929924 Long EC CORP CN N 2 N N N Aier Eye Hospital Group Co. Ltd. N/A Aier Eye Hospital Group Co. Ltd., Class A N/A 2188722.00000000 NS 5420359.92000000 1.579551694463 Long EC CORP CN N 2 N N N Sino Wealth Electronic Ltd. N/A Sino Wealth Electronic Ltd., Class A N/A 967220.00000000 NS 3335208.84000000 0.971916044758 Long EC CORP CN N 2 N N N Midea Group Co. Ltd. 3003003TRPHLHZD2IF61 Midea Group Co. Ltd., Class A N/A 663316.00000000 NS 5061841.69000000 1.475075592129 Long EC CORP CN N 2 N N N Shenzhen Inovance Technology Co. Ltd. N/A Shenzhen Inovance Technology Co. Ltd., Class A N/A 892300.00000000 NS 8156860.80000000 2.376997743379 Long EC CORP CN N 2 N N N Wuliangye Yibin Co. Ltd. N/A Wuliangye Yibin Co. Ltd., Class A N/A 371588.00000000 NS 8010071.70000000 2.334221806900 Long EC CORP CN N 2 N N N New Horizon Health Ltd. 6556003WN0RS45SU3L67 New Horizon Health Ltd. N/A 694000.00000000 NS 1657447.10000000 0.482998069118 Long EC CORP KY N 2 N N Institutional Fiduciary Trust Money Market Portfolio N/A Institutional Fiduciary Trust Money Market Portfolio N/A 1670507.60000000 NS USD 1670507.60000000 0.486804040532 Long STIV RF US N 1 N N Contemporary Amperex Technology Co. Ltd. 300300KINDY1K0E9I032 Contemporary Amperex Technology Co. Ltd., Class A N/A 321364.00000000 NS 8979697.63000000 2.616781323856 Long EC CORP CN N 2 N N N BYD Co. Ltd. 5299005557VL7ULJ7A69 BYD Co. Ltd., Class H N/A 127000.00000000 NS 3913023.74000000 1.140297576215 Long EC CORP CN N 2 N N N SF Holding Co. Ltd. N/A SF Holding Co. Ltd., Class A N/A 1029500.00000000 NS 5787131.92000000 1.686433034934 Long EC CORP CN N 2 N N N China Feihe Ltd. N/A China Feihe Ltd. N/A 4300000.00000000 NS 2526710.03000000 0.736310718883 Long EC CORP KY N 2 N N N Ping An Insurance Group Co. of China Ltd. 529900M9MC28JLN35U89 Ping An Insurance Group Co. of China Ltd., Class A N/A 494400.00000000 NS 3296823.24000000 0.960730064414 Long EC CORP CN N 2 N N N Institutional Fiduciary Trust - Money Market Portfolio 549300M4TP89K77LG374 Institutional Fiduciary Trust - Money Market Portfolio 457756500 6260949.38100000 NS USD 6260949.38000000 1.824508583948 Long STIV RF US N 1 N N N East Money Information Co. Ltd. 836800ZFB0ZEK3KKW487 East Money Information Co. Ltd., Class A N/A 2874426.00000000 NS 6032790.63000000 1.758020648555 Long EC CORP CN N 2 N N N NARI Technology Co. Ltd. N/A NARI Technology Co. Ltd., Class A N/A 2980215.00000000 NS 9070807.99000000 2.643331871356 Long EC CORP CN N 2 N N N Fuyao Glass Industry Group Co. Ltd. 549300AS5CSLWETN0P64 Fuyao Glass Industry Group Co. Ltd., Class A N/A 886922.00000000 NS 4497243.13000000 1.310545445551 Long EC CORP CN N 2 N N N China Yangtze Power Co. Ltd. 3003008VX8JFJXA6QP74 China Yangtze Power Co. Ltd., Class A N/A 1865020.00000000 NS 5692782.83000000 1.658938686370 Long EC CORP CN N 2 N N N GoodWe Technologies Co. Ltd. N/A GoodWe Technologies Co. Ltd., Class A N/A 203661.00000000 NS 3705527.80000000 1.079831007859 Long EC CORP CN N 2 N N N 2023-10-30 Templeton Dragon Fund, Inc. Monica Krogh Monica Krogh Assistant Treasurer XXXX NPORT-EX 2 TDFI.htm
Not
FDIC
Insured
May
Lose
Value
No
Bank
Guarantee
TLTDF-Q3PH
1
Consolidated
Schedule
of
Investments
(unaudited)
Templeton
Dragon
Fund,
Inc.
2
Notes
to
Consolidated
Schedule
of
Investments
5
Templeton
Dragon
Fund,
Inc.
Consolidated
Schedule
of
Investments
(unaudited),
September
30,
2023
Quarterly
Consolidated
Schedule
of
Investments
See
Notes
to
Consolidated
Schedule
of
Investments.
2
l
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
96.4%
Air
Freight
&
Logistics
1.7%
a
SF
Holding
Co.
Ltd.,
A
..................................
China
1,029,500
$
5,787,132
Automobile
Components
1.3%
a
Fuyao
Glass
Industry
Group
Co.
Ltd.,
A
.....................
China
886,922
4,497,243
Automobiles
2.0%
a
BYD
Co.
Ltd.,
A
.......................................
China
86,000
2,813,378
BYD
Co.
Ltd.,
H
......................................
China
127,000
3,913,024
6,726,402
Banks
5.1%
a
China
Merchants
Bank
Co.
Ltd.,
A
.........................
China
1,163,800
5,296,006
China
Merchants
Bank
Co.
Ltd.,
H
.........................
China
1,604,448
6,661,249
b
Postal
Savings
Bank
of
China
Co.
Ltd.,
H,
144A,
Reg
S
.........
China
11,001,649
5,540,029
17,497,284
Beverages
8.2%
China
Resources
Beer
Holdings
Co.
Ltd.
....................
China
738,706
4,035,266
a
Kweichow
Moutai
Co.
Ltd.,
A
.............................
China
65,445
16,236,852
a
Wuliangye
Yibin
Co.
Ltd.,
A
..............................
China
371,588
8,010,072
28,282,190
Broadline
Retail
8.6%
c
Alibaba
Group
Holding
Ltd.
..............................
China
2,113,738
22,918,273
JD.com,
Inc.,
A
.......................................
China
452,312
6,580,822
29,499,095
Capital
Markets
2.7%
a
East
Money
Information
Co.
Ltd.,
A
........................
China
2,874,426
6,032,791
Hong
Kong
Exchanges
&
Clearing
Ltd.
.....................
Hong
Kong
90,257
3,349,794
9,382,585
Chemicals
1.2%
a
Guangzhou
Tinci
Materials
Technology
Co.
Ltd.,
A
.............
China
1,123,280
4,170,669
Electrical
Equipment
8.4%
a
Contemporary
Amperex
Technology
Co.
Ltd.,
A
...............
China
321,364
8,979,698
a
GoodWe
Technologies
Co.
Ltd.,
A
.........................
China
203,661
3,705,528
a
Hongfa
Technology
Co.
Ltd.,
A
............................
China
1,535,209
7,077,655
a
NARI
Technology
Co.
Ltd.,
A
.............................
China
2,980,215
9,070,808
28,833,689
Entertainment
3.4%
NetEase,
Inc.
........................................
China
582,379
11,677,801
Food
Products
2.3%
b
China
Feihe
Ltd.,
144A,
Reg
S
...........................
China
4,300,000
2,526,710
a
Inner
Mongolia
Yili
Industrial
Group
Co.
Ltd.,
A
...............
China
1,446,200
5,277,485
7,804,195
Health
Care
Equipment
&
Supplies
2.0%
a
Shenzhen
Mindray
Bio-Medical
Electronics
Co.
Ltd.,
A
..........
China
181,501
6,746,598
Health
Care
Providers
&
Services
2.1%
a
Aier
Eye
Hospital
Group
Co.
Ltd.,
A
........................
China
2,188,722
5,420,360
b,c,d
New
Horizon
Health
Ltd.,
144A,
Reg
S
.....................
China
694,000
1,657,447
7,077,807
Templeton
Dragon
Fund,
Inc.
Consolidated
Schedule
of
Investments
(unaudited)
See
Notes
to
Consolidated
Schedule
of
Investments.
Quarterly
Consolidated
Schedule
of
Investments
3
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Hotels,
Restaurants
&
Leisure
5.1%
b,c
Meituan
Dianping,
B,
144A,
Reg
S
........................
China
759,943
$
11,001,432
Yum
China
Holdings,
Inc.
...............................
China
117,578
6,551,446
17,552,878
Household
Durables
2.7%
a
Haier
Smart
Home
Co.
Ltd.,
A
............................
China
1,278,400
4,156,600
a
Midea
Group
Co.
Ltd.,
A
................................
China
663,316
5,061,842
9,218,442
Independent
Power
and
Renewable
Electricity
Producers
1.6%
a
China
Yangtze
Power
Co.
Ltd.,
A
..........................
China
1,865,020
5,692,783
Insurance
4.2%
a
Ping
An
Insurance
Group
Co.
of
China
Ltd.,
A
................
China
494,400
3,296,823
Ping
An
Insurance
Group
Co.
of
China
Ltd.,
H
................
China
1,987,427
11,272,345
14,569,168
Interactive
Media
&
Services
13.3%
c
Baidu,
Inc.,
ADR
......................................
China
30,181
4,054,817
c
Baidu,
Inc.,
A
.........................................
China
559,500
9,417,061
Tencent
Holdings
Ltd.
..................................
China
828,026
32,098,591
45,570,469
Life
Sciences
Tools
&
Services
3.0%
b,d
WuXi
AppTec
Co.
Ltd.,
H,
144A,
Reg
S
.....................
China
274,008
3,267,686
b,c
Wuxi
Biologics
Cayman,
Inc.,
144A,
Reg
S
..................
China
1,195,850
6,950,332
10,218,018
Machinery
3.5%
a
Shenzhen
Inovance
Technology
Co.
Ltd.,
A
..................
China
892,300
8,156,861
Weichai
Power
Co.
Ltd.,
H
..............................
China
2,826,261
3,830,854
11,987,715
Media
4.2%
a
Focus
Media
Information
Technology
Co.
Ltd.,
A
..............
China
13,519,216
13,264,972
b,c
Mobvista,
Inc.,
144A,
Reg
S
.............................
China
3,098,200
1,246,291
14,511,263
Pharmaceuticals
2.6%
a
Jiangsu
Hengrui
Pharmaceuticals
Co.
Ltd.,
A
.................
China
1,445,227
8,938,035
a,c,e,f
Kangmei
Pharmaceutical
Co.
Ltd.
.........................
China
673,786
114,541
9,052,576
Real
Estate
Management
&
Development
1.3%
China
Resources
Land
Ltd.
..............................
China
1,111,375
4,413,566
Semiconductors
&
Semiconductor
Equipment
1.0%
a
Sino
Wealth
Electronic
Ltd.,
A
............................
China
967,220
3,335,209
Software
1.3%
a
Hundsun
Technologies,
Inc.,
A
............................
China
976,621
4,362,882
Textiles,
Apparel
&
Luxury
Goods
3.6%
ANTA
Sports
Products
Ltd.
..............................
China
1,110,075
12,421,407
Total
Common
Stocks
(Cost
$313,853,120)
.....................................
330,889,066
Templeton
Dragon
Fund,
Inc.
Consolidated
Schedule
of
Investments
(unaudited)
Quarterly
Consolidated
Schedule
of
Investments
See
Notes
to
Consolidated
Schedule
of
Investments.
4
Short
Term
Investments
2.3%
a
a
Country
Shares
a
Value
a
a
a
Money
Market
Funds
1.8%
g,h
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
5.019%
....
United
States
6,266,148
$
6,266,148
Total
Money
Market
Funds
(Cost
$6,266,148)
...................................
6,266,148
a
a
a
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
0.5%
Money
Market
Funds
0.5%
g,h
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
5.019%
....
United
States
1,670,508
1,670,508
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$1,670,508)
............................................................
1,670,508
Total
Short
Term
Investments
(Cost
$7,936,656
)
.................................
7,936,656
a
Total
Investments
(Cost
$321,789,776)
98.7%
...................................
$338,825,722
Other
Assets,
less
Liabilities
1.3%
.............................................
4,357,343
Net
Assets
100.0%
...........................................................
$343,183,065
See
Abbreviations
on
page
8
.
a
The
security
is
owned
by
Templeton
China
Opportunities
Fund,
Ltd.,
a
wholly-owned
subsidiary
of
the
Fund.
See
Note
5.
b
Security
was
purchased
pursuant
to
Rule
144A
or
Regulation
S
under
the
Securities
Act
of
1933.
144A
securities
may
be
sold
in
transactions
exempt
from
registration
only
to
qualified
institutional
buyers
or
in
a
public
offering
registered
under
the
Securities
Act
of
1933.
Regulation
S
securities
cannot
be
sold
in
the
United
States
without
either
an
effective
registration
statement
filed
pursuant
to
the
Securities
Act
of
1933,
or
pursuant
to
an
exemption
from
registration.
At
September
30,
2023,
the
aggregate
value
of
these
securities
was
$32,189,927,
representing
9.4%
of
net
assets.
c
Non-income
producing.
d
A
portion
or
all
of
the
security
is
on
loan
at
September
30,
2023.
e
Fair
valued
using
significant
unobservable
inputs.
See
Note
6
regarding
fair
value
measurements.
f
See
Note
3
regarding
restricted
securities.
g
See
Note
4
regarding
investments
in
affiliated
management
investment
companies.
h
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
Templeton
Dragon
Fund,
Inc.
5
Quarterly
Consolidated
Schedule
of
Investments
Notes
to
Consolidated
Schedule
of
Investments
(unaudited)
1.
Organization
Templeton
Dragon
Fund,
Inc. (Fund)
is
registered
under
the
Investment
Company
Act
of
1940
(1940
Act)
as
a
closed-end
management
investment
company.
The
Fund
follows
the
accounting
and
reporting
guidance
in
Financial
Accounting
Standards
Board
(FASB)
Accounting
Standards
Codification
Topic
946,
Financial
Services
Investment
Companies
(ASC
946)
and
applies
the
specialized
accounting
and
reporting
guidance
in
U.S.
Generally
Accepted
Accounting
Principles
(U.S.
GAAP),
including,
but
not
limited
to,
ASC
946. 
2. Financial
Instrument
Valuation
The
Fund's investments
in
financial
instruments
are
carried
at
fair
value
daily.
Fair
value
is
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
on
the
measurement
date.
The
Fund
calculates the
net
asset
value
(NAV)
per
share
each
business
day
as
of
4
p.m.
Eastern
time
or
the
regularly
scheduled
close
of
the
New
York
Stock
Exchange
(NYSE),
whichever
is
earlier.
Under
compliance
policies
and
procedures
approved
by
the
Fund’s
Board
of
Directors
(the
Board),
the
Board
has
designated
the
Fund’s
investment
manager
as
the
valuation
designee
and
has
responsibility
for
oversight
of
valuation.
The
investment
manager
is
assisted
by
the
Fund’s
administrator
in
performing
this
responsibility,
including
leading
the
cross-functional
Valuation
Committee
(VC).
The
Fund
may
utilize
independent
pricing
services,
quotations
from
securities
and
financial
instrument
dealers,
and
other
market
sources
to
determine
fair
value. 
Equity
securities
listed
on
an
exchange
or
on
the
NASDAQ
National
Market
System
are
valued
at
the
last
quoted
sale
price
or
the
official
closing
price
of
the
day,
respectively.
Foreign
equity
securities
are
valued
as
of
the
close
of
trading
on
the
foreign
stock
exchange
on
which
the
security
is
primarily
traded
or
as
of
4
p.m.
Eastern
time.
The
value
is
then
converted
into
its
U.S.
dollar
equivalent
at
the
foreign
exchange
rate
in
effect
at
4
p.m. Eastern
time
on
the
day
that
the
value
of
the
security
is
determined.
Over-the-counter
(OTC)
securities
are
valued
within
the
range
of
the
most
recent
quoted
bid
and
ask
prices.
Securities
that
trade
in
multiple
markets
or
on
multiple
exchanges
are
valued
according
to
the
broadest
and
most
representative
market.
Certain
equity
securities
are
valued
based
upon
fundamental
characteristics
or
relationships
to
similar
securities. 
Debt
securities
generally
trade
in
the
OTC
market
rather
than
on
a
securities
exchange.
The Fund's
pricing
services
use
multiple
valuation
techniques
to
determine
fair
value.
In
instances
where
sufficient
market
activity
exists,
the
pricing
services
may
utilize
a
market-based
approach
through
which
quotes
from
market
makers
are
used
to
determine
fair
value.
In
instances
where
sufficient
market
activity
may
not
exist
or
is
limited,
the
pricing
services
also
utilize
proprietary
valuation
models
which
may
consider
market
characteristics
such
as
benchmark
yield
curves,
credit
spreads,
estimated
default
rates,
anticipated
market
interest
rate
volatility,
coupon
rates,
anticipated
timing
of
principal
repayments,
underlying
collateral,
and
other
unique
security
features
in
order
to
estimate
the
relevant
cash
flows,
which
are
then
discounted
to
calculate
the
fair
value.
Securities
denominated
in
a
foreign
currency
are
converted
into
their
U.S.
dollar
equivalent
at
the
foreign
exchange
rate
in
effect
at
4
p.m.
Eastern
time
on
the
date
that
the
values
of
the
foreign
debt
securities
are
determined.
Investments
in
open-end
mutual
funds
are
valued
at
the
closing
NAV.
The
Fund
has procedures
to
determine
the
fair
value
of
financial
instruments
for
which
market
prices
are
not
reliable
or
readily
available.
Under
these
procedures,
the
Fund
primarily employs
a
market-based
approach
which
may
use
related
or
comparable
assets
or
liabilities,
recent
transactions,
market
multiples,
and
other
relevant
information
for
the
investment
to
determine
the
fair
value
of
the
investment.
An
income-based
valuation
approach
may
also
be
used
in
which
the
anticipated
future
cash
flows
of
the
investment
are
discounted
to
calculate
fair
value.
Discounts
may
also
be
applied
due
to
the
nature
or
duration
of
any
restrictions
on
the
disposition
of
the
investments.
Due
to
the
inherent
uncertainty
of
valuations
of
such
investments,
the
fair
values
may
differ
significantly
from
the
values
that
would
have
been
used
had
an
active
market
existed. 
Templeton
Dragon
Fund,
Inc.
Notes
to
Consolidated
Schedule
of
Investments
(unaudited)
6
Quarterly
Consolidated
Schedule
of
Investments
Trading
in
securities
on
foreign
securities
stock
exchanges
and
OTC
markets
may
be
completed
before
4
p.m.
Eastern
time.
In
addition,
trading
in
certain
foreign
markets
may
not
take
place
on
every
Fund’s
business
day.
Events
can
occur
between
the
time
at
which
trading
in
a
foreign
security
is
completed
and
4
p.m.
Eastern
time
that
might
call
into
question
the
reliability
of
the
value
of
a
portfolio
security
held
by
the
Fund.
As
a
result,
differences
may
arise
between
the
value
of
the
Fund’s
portfolio securities
as
determined
at
the
foreign
market
close
and
the
latest
indications
of
value
at
4
p.m.
Eastern
time.
In
order
to
minimize
the
potential
for
these
differences,
an
independent
pricing
service
may
be
used
to
adjust
the
value
of
the
Fund’s
portfolio
securities
to
the
latest
indications
of
fair
value
at 4
p.m
Eastern
time.
At
September
30,
2023,
certain
securities
may
have
been
fair
valued
using
these
procedures,
in
which
case
the
securities
were
categorized
as
Level
2
within
the
fair
value
hierarchy
(referred
to
as
"market
level
fair
value").
See
the
Fair
Value
Measurements
note
for
more
information.
When
the
last
day
of
the
reporting
period
is
a
non-business
day,
certain
foreign
markets
may
be
open
on
those
days
that
the
Fund’s
NAV
is
not
calculated,
which
could
result
in
differences
between
the
value
of
the
Fund’s
portfolio
securities
on
the
last
business
day
and
the
last
calendar
day
of
the
reporting
period.
Any
security
valuation
changes
due
to
an
open
foreign
market
are
adjusted
and
reflected
by
the
Fund for
financial
reporting
purposes.
3.
Restricted
Securities
At
September
30,
2023,
investments
in
restricted
securities,
excluding
securities
exempt
from
registration
under
the
Securities
Act
of
1933,
were
as
follows:
4.
Investments
in
Affiliated
Management
Investment
Companies 
The
Fund
invests
in
one
or
more
affiliated
management
investment
companies.
As
defined
in
the
1940
Act,
an
investment
is
deemed
to
be
a
“Controlled
Affiliate”
of
a
fund
when
a
fund
owns,
either
directly
or
indirectly,
25%
or
more
of
the
affiliated
fund’s
outstanding
shares
or
has
the
power
to
exercise
control
over
management
or
policies
of
such
fund.
The
Fund
does
not
invest for
purposes
of
exercising
a
controlling
influence
over
the
management
or
policies.
During
the
period
ended
September
30,
2023,
the
Fund
held
investments
in
affiliated
management
investment
companies
as
follows: 
Shares
Issuer
Acquisition
Date
Cost
Value
Templeton
Dragon
Fund,
Inc
.
673,786
Kangmei
Pharmaceutical
Co
.
Ltd
.
................
4/06/22
$
$
1
14
,
541
Total
Restricted
Securities
(Value
is
0.0%
of
Net
Assets)
.............
$—
$114,541
Rounds
to
less
than
0.1%
of
net
assets.
    aa
Value
at
Beginning
of
Period
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Period
Number
of
Shares
Held
at
End
of
Period
Investment
Income
a      
a  
a  
a  
a  
a  
a  
a  
Templeton
Dragon
Fund,
Inc.
Non-Controlled
Affiliates
Dividends
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
5.019%
$3,959,472
$28,051,179
$(25,744,503)
$—
$—
$6,266,148
6,266,148
$99,264
2. Financial
Instrument
Valuation
(continued)
Templeton
Dragon
Fund,
Inc.
Notes
to
Consolidated
Schedule
of
Investments
(unaudited)
7
Quarterly
Consolidated
Schedule
of
Investments
5.
Investments
in
Templeton
China
Opportunities
Fund,
Ltd.
(China
Fund)  
The
Fund
invests
in
certain
China
A-shares
through
its
investment
in
the
China
Fund.
The
China
Fund
is
a
Cayman
Islands
exempted
company,
and
is
a
wholly-owned
subsidiary
of
the
Fund,
and
is
able
to
invest
directly
in
China
A-shares
consistent
with
the
investment
objective
of
the
Fund.
At September
30,
2023,
the
China
Fund’s
investments
as
well
as
any
other
assets
and
liabilities
of
the
China
Fund
are
reflected
in
the
Fund’s
Consolidated Schedule
of
Investments.
At
September
30,
2023, the
net
assets
of
the
China
Fund
were
$161,650,705,
representing
47.1%
of
the
Fund’s
consolidated
net
assets.
The
China
Fund
gains
access
to
the
A-shares
market
through
Templeton
Investment
Counsel,
LLC
(TIC),
which
serves
as
the
registered
Qualified
Foreign
Institutional
Investor
(QFII)
for
the
China
Fund.
Investment
decisions
related
to
the
China
Fund
A-shares
are
specific
to
the
Fund
and
it
bears
the
resultant
economic
and
tax
consequences
of
its
holdings
and
transactions
in
A-shares.
The
China
Fund
is
subject
to
certain
restrictions
and
administrative
processes
relating
to
its
ability
to
repatriate
cash
balances,
investment
proceeds,
and
earnings
associated
with
its
A-shares
and
may
incur
substantial
delays
in
gaining
access
to
its
assets
or
a
loss
of
value
in
the
event
of
noncompliance
with
applicable
Chinese
rules
or
requirements. 
6. Fair
Value
Measurements 
The
Fund
follows
a
fair
value
hierarchy
that
distinguishes
between
market
data
obtained
from
independent
sources
(observable
inputs)
and
the
Fund's
own
market
assumptions
(unobservable
inputs).
These
inputs
are
used
in
determining
the
value
of
the
Fund's
financial
instruments
and
are
summarized
in
the
following
fair
value
hierarchy:
Level
1
quoted
prices
in
active
markets
for
identical
financial
instruments
Level 2
other
significant
observable
inputs
(including
quoted
prices
for
similar
financial
instruments,
interest
rates,
prepayment
speed,
credit
risk,
etc.)
Level 3
significant
unobservable
inputs
(including
the
Fund's own
assumptions
in
determining
the
fair
value
of
financial
instruments)
The
input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level.
A
summary
of
inputs
used
as
of
September
30,
2023,
in
valuing
the
Fund's
assets
carried
at
fair
value,
is
as
follows:
    aa
Value
at
Beginning
of
Period
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Period
Number
of
Shares
Held
at
End
of
Period
Investment
Income
a      
a  
a  
a  
a  
a  
a  
a  
Templeton
Dragon
Fund,
Inc.
(continued)
Non-Controlled
Affiliates
Income
from
securities
loaned
Institutional
Fiduciary
Trust
-
Money
Market
Portfolio,
5.019%
$1,706,584
$13,901,137
$(13,937,213)
$—
$—
$1,670,508
1,670,508
$30,047
Total
Affiliated
Securities
...
$5,666,056
$41,952,316
$(39,681,716)
$—
$—
$7,936,656
$129,311
4.
Investments
in
Affiliated
Management
Investment
Companies 
(continued)
Templeton
Dragon
Fund,
Inc.
Notes
to
Consolidated
Schedule
of
Investments
(unaudited)
8
Quarterly
Consolidated
Schedule
of
Investments
A
reconciliation
in
which
Level
3
inputs
are
used
in
determining
fair
value
is
presented
when
there
are
significant
Level
3
assets
and/or
liabilities
at
the
beginning
and/or
end
of
the
period.
Abbreviations
Level
1
Level
2
Level
3
Total
Templeton
Dragon
Fund,
Inc.
Assets:
Investments
in
Securities:
Common
Stocks
:
Air
Freight
&
Logistics
...................
$
$
5,787,132
$
$
5,787,132
Automobile
Components
.................
4,497,243
4,497,243
Automobiles
..........................
6,726,402
6,726,402
Banks
...............................
17,497,284
17,497,284
Beverages
...........................
28,282,190
28,282,190
Broadline
Retail
.......................
29,499,095
29,499,095
Capital
Markets
........................
9,382,585
9,382,585
Chemicals
...........................
4,170,669
4,170,669
Electrical
Equipment
....................
28,833,689
28,833,689
Entertainment
.........................
11,677,801
11,677,801
Food
Products
........................
7,804,195
7,804,195
Health
Care
Equipment
&
Supplies
.........
6,746,598
6,746,598
Health
Care
Providers
&
Services
..........
7,077,807
7,077,807
Hotels,
Restaurants
&
Leisure
.............
6,551,446
11,001,432
17,552,878
Household
Durables
....................
9,218,442
9,218,442
Independent
Power
and
Renewable
Electricity
Producers
..........................
5,692,783
5,692,783
Insurance
............................
14,569,168
14,569,168
Interactive
Media
&
Services
..............
4,054,817
41,515,652
45,570,469
Life
Sciences
Tools
&
Services
............
10,218,018
10,218,018
Machinery
............................
11,987,715
11,987,715
Media
...............................
1,246,291
13,264,972
14,511,263
Pharmaceuticals
.......................
8,938,035
114,541
9,052,576
Real
Estate
Management
&
Development
....
4,413,566
4,413,566
Semiconductors
&
Semiconductor
Equipment
.
3,335,209
3,335,209
Software
.............................
4,362,882
4,362,882
Textiles,
Apparel
&
Luxury
Goods
..........
12,421,407
12,421,407
Short
Term
Investments
...................
7,936,656
7,936,656
Total
Investments
in
Securities
...........
$19,789,210
$318,921,971
a
$114,541
$338,825,722
a
Includes
foreign
securities
valued
at
$318,921,971,
which
were
categorized
as
Level
2
as
a
result
of
the
application
of
market
level
fair
value
procedures.
See
the
Financial
Instrument
Valuation
note
for
more
information.
Selected
Portfolio
ADR
American
Depositary
Receipt
6. Fair
Value
Measurements 
(continued)
For
additional
information
on
the
Fund's
significant
accounting
policies,
please
refer
to
the Fund's
most
recent
semiannual
or
annual
shareholder
report.